Cargando…

Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial

BACKGROUND: Placebo medications, by definition, are composed of inactive ingredients that have no physiological effect on symptoms. Nonetheless, administration of placebo in randomized controlled trials (RCTs) and in clinical settings has been demonstrated to have significant impact on many physical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ballou, Sarah, Kaptchuk, Ted J., Hirsch, William, Nee, Judy, Iturrino, Johanna, Hall, Kathryn T., Kelley, John M., Cheng, Vivian, Kirsch, Irving, Jacobson, Eric, Conboy, Lisa, Lembo, Anthony, Davis, Roger B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445390/ https://www.ncbi.nlm.nih.gov/pubmed/28545508 http://dx.doi.org/10.1186/s13063-017-1964-x

Ejemplares similares

Patients’ experiences treated with open-label placebo versus double-blind placebo: a mixed methods qualitative study
por: Haas, Julia W., et al.
Publicado: (2022)

Genomic Effects Associated With Response to Placebo Treatment in a Randomized Trial of Irritable Bowel Syndrome
por: Wang, Rui-Sheng, et al.
Publicado: (2022)

Genotypes of Pain and Analgesia in a Randomized Trial of Irritable Bowel Syndrome
por: Vollert, Jan, et al.
Publicado: (2022)

Catechol-O-Methyltransferase val158met Polymorphism Predicts Placebo Effect in Irritable Bowel Syndrome
por: Hall, Kathryn T., et al.
Publicado: (2012)

Pelvic Floor Symptom Related Distress in Chronic Constipation Correlates With a Diagnosis of Irritable Bowel Syndrome With Constipation and Constipation Severity but Not Pelvic Floor Dyssynergia
por: Singh, Prashant, et al.
Publicado: (2019)

Placebos without Deception: A Randomized Controlled Trial in Irritable Bowel Syndrome
por: Kaptchuk, Ted J., et al.
Publicado: (2010)

Randomized Clinical Trial: Crofelemer Treatment in Women With Diarrhea-Predominant Irritable Bowel Syndrome
por: Nee, Judy, et al.
Publicado: (2019)

Irritable bowel syndrome and diet
por: Portincasa, Piero, et al.
Publicado: (2017)

Diminished androgen levels are linked to irritable bowel syndrome and cause bowel dysfunction in mice
por: Rastelli, Daniella, et al.
Publicado: (2022)

“Maybe I Made Up the Whole Thing”: Placebos and Patients’ Experiences in a Randomized Controlled Trial
por: Kaptchuk, Ted J., et al.
Publicado: (2009)

Open-label placebo treatment in chronic low back pain: a randomized controlled trial
por: Carvalho, Cláudia, et al.
Publicado: (2016)

Effect of antibiotic pretreatment on bacterial engraftment after Fecal Microbiota Transplant (FMT) in IBS-D
por: Singh, Prashant, et al.
Publicado: (2022)

Emergency department burden of hyperemesis gravidarum in the United States from 2006 to 2014
por: Geeganage, Grace, et al.
Publicado: (2023)

Conscientiousness is modified by genetic variation in catechol-O-methyltransferase to reduce symptom complaints in IBS patients
por: Hall, Kathryn T, et al.
Publicado: (2015)

P02.145. Relationship of treatment beliefs to subject blinding: the case of a placebo-controlled RCT in Irritable Bowel Syndrome
por: Quilty, M, et al.
Publicado: (2012)

Psychological Interventions for Irritable Bowel Syndrome and Inflammatory Bowel Diseases
por: Ballou, Sarah, et al.
Publicado: (2017)

A Pilot Study of the Effect of Daikenchuto on Rectal Sensation in Patients with Irritable Bowel Syndrome
por: Acosta, Andres, et al.
Publicado: (2016)

Are All Placebo Effects Equal? Placebo Pills, Sham Acupuncture, Cue Conditioning and Their Association
por: Kong, Jian, et al.
Publicado: (2013)

A Neural Mechanism for Nonconscious Activation of Conditioned Placebo and Nocebo Responses
por: Jensen, Karin B., et al.
Publicado: (2015)

Placebo Responses in Genetically Determined Intellectual Disability: A Meta-Analysis
por: Curie, Aurore, et al.
Publicado: (2015)

Frequency of Adverse Events in the Placebo Arms of COVID-19 Vaccine Trials: A Systematic Review and Meta-analysis
por: Haas, Julia W., et al.
Publicado: (2022)

Placebo by proxy
por: Grelotti, David J, et al.
Publicado: (2011)

Open-Label Placebo Treatment for Cancer-Related Fatigue: A Randomized-Controlled Clinical Trial
por: Hoenemeyer, Teri W., et al.
Publicado: (2018)

Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double‐blind, placebo‐controlled trials
por: Schoenfeld, P., et al.
Publicado: (2014)

Open-label placebos for menopausal hot flushes: a randomized controlled trial
por: Pan, Yiqi, et al.
Publicado: (2020)

Tenapanor Treatment of Patients With Constipation-Predominant Irritable Bowel Syndrome: A Phase 2, Randomized, Placebo-Controlled Efficacy and Safety Trial
por: Chey, William D, et al.
Publicado: (2017)

Repeat treatment with rifaximin improves irritable bowel syndrome-related quality of life: a secondary analysis of a randomized, double-blind, placebo-controlled trial
por: Cash, Brooks D., et al.
Publicado: (2017)

Patient-Provider Interactions Affect Symptoms in Gastroesophageal Reflux Disease: A Pilot Randomized, Double-Blind, Placebo-Controlled Trial
por: Dossett, Michelle L., et al.
Publicado: (2015)

An Exploratory Analysis of the Association Between Catechol-O-Methyltransferase and Response to a Randomized Open-Label Placebo Treatment for Cancer-Related Fatigue
por: Hoenemeyer, Teri W., et al.
Publicado: (2021)

Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015)

Symptom perception, placebo effects, and the Bayesian brain
por: Ongaro, Giulio, et al.
Publicado: (2019)

Placebo Effect in Clinical Trial Design for Irritable Bowel Syndrome
por: Shah, Eric, et al.
Publicado: (2014)

Efficacy of Tenapanor in Treating Patients With Irritable Bowel Syndrome With Constipation: A 12-Week, Placebo-Controlled Phase 3 Trial (T3MPO-1)
por: Chey, William D., et al.
Publicado: (2020)

“Let’s see what happens:”—Women’s experiences of open-label placebo treatment for menopausal hot flushes in a randomized controlled trial
por: Pan, Yiqi, et al.
Publicado: (2022)

Efficacy of Tenapanor in Treating Patients With Irritable Bowel Syndrome With Constipation: A 26-Week, Placebo-Controlled Phase 3 Trial (T3MPO-2)
por: Chey, William D., et al.
Publicado: (2021)

Abdominal Pain Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea
por: Lembo, Anthony, et al.
Publicado: (2020)

Irritable bowel syndrome symptom severity improves equally with probiotic and placebo
por: Lyra, Anna, et al.
Publicado: (2016)

Kimchi improves irritable bowel syndrome: results of a randomized, double-blind placebo-controlled study
por: Kim, Hee-Young, et al.
Publicado: (2022)

Imaginary pills and open-label placebos can reduce test anxiety by means of placebo mechanisms
por: Buergler, Sarah, et al.
Publicado: (2023)

Probiotic vs. Placebo in Irritable Bowel Syndrome:A Randomized Controlled Trial
por: Amirimani, Behnaz, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4gdis349eokpvqnbuf5r372gpg